JPS6095357A - Analyzing device for crinical analysis - Google Patents
Analyzing device for crinical analysisInfo
- Publication number
- JPS6095357A JPS6095357A JP58204291A JP20429183A JPS6095357A JP S6095357 A JPS6095357 A JP S6095357A JP 58204291 A JP58204291 A JP 58204291A JP 20429183 A JP20429183 A JP 20429183A JP S6095357 A JPS6095357 A JP S6095357A
- Authority
- JP
- Japan
- Prior art keywords
- chamber
- blood
- sample
- analytical device
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
【発明の詳細な説明】
本発明は血液や尿等を臨床化学分析Jるための新規4f
分析デバイスに関するものである。Detailed Description of the Invention The present invention is a novel 4f method for clinical chemical analysis of blood, urine, etc.
It concerns an analytical device.
今日、自動臨床化学分析装置の若しい普及により血液や
尿の検査は9.<i時間で正1i1「に行t「われるJ
、うになり、臨床分野においC大いに貢献しCいる。Today, due to the widespread use of automated clinical chemistry analyzers, blood and urine tests are now only 9. <In the i time, go to the correct 1i1''
, and has made significant contributions in the clinical field.
しかしながら、従来の臨床分析は第1図に示り様に採面
1の後、一定期間静置・凝固しく2)、3の血清分離・
分注という過程を経−(血1jl(分を分離し、場合に
よっては更に蛋白質を除去した後、分析装置に導入して
自動分析(4)づるど言う大変に厄介な作業を必要とし
、分析までに手間と時間が11トリづぎる問題を有して
いる。[illも、特に血球分の分離には遠心力場を利
用した)仝心分離1幾が使用されるが、分nIされた血
液は試オ′81管の底部に血球分が、又その上部に白油
、又は血すΩが液体の状態で存在し、このにうにして分
離された血)青(又CL面県)をビベツ1〜で吸い」ニ
げ’C’r)和装附の試!!’jl?3に移し換え(い
る。この様な作業は非常に厄介(・あり、緊急を要りる
血液の検査に間に合わない場合が多い。However, in conventional clinical analysis, as shown in Figure 1, after the surface is taken (1), it is left to stand for a certain period of time and coagulated (2), and serum separation (3) is performed.
Through the process of dispensing, 1 liter of blood is separated, and in some cases, proteins are further removed, and then introduced into an analyzer for automatic analysis (4). This method requires a lot of time and effort.[Ill also uses a centrifugal force field to separate blood cells. There are blood cells at the bottom of the sample tube and white oil or blood in liquid form at the top, and the blood separated in this way is blue (also CL surface prefecture). Sucking in Bibetsu 1~'Nige'C'r) Trial with Japanese clothing! ! 'jl? 3. This kind of work is extremely troublesome, and there are many cases where urgent blood tests cannot be completed in time.
而して、本発明は上記従来の欠点を解消覆るもの(゛、
第1図にd3いて点線で示すように採血後直らに分析で
き、静置や面清分薗1・分針等の作業の全く不要4f新
現な分析デバイスを提供りることに目的をイーjりる。Therefore, the present invention eliminates and overcomes the above-mentioned conventional drawbacks (゛,
As shown by the dotted line at d3 in Figure 1, the purpose is to provide a new analytical device that can be analyzed immediately after blood collection, and does not require any work such as leaving it still, washing the surface, or using a minute hand. Rir.
本発明の(f4或は単−基体内に多孔質の薄い透析I′
、)により分前された2つの部屋を形成し、第1の部屋
には分析リベき試料)1夕を導入し、第2の部屋には固
定化酵素を充填すると共に透析膜を通過した試わ1液を
抽出及び若しくは該試料液と反応りる溶液を注入し、・
前記第2の部屋に連通して同−基体内に検出セル部を形
成し、+’+ii記第20部に内(反応した試オ′31
溶液を該検出レル部に導入しC所定の分析を行(7うよ
うした臨床分析用分析デバイスに特徴がある。The present invention (f4 or mono-substrate with porous thin dialysis I'
, ), the first chamber was filled with the sample to be analyzed ( ), and the second chamber was filled with the immobilized enzyme and the sample that had passed through the dialysis membrane. Extract the first liquid and/or inject a solution that reacts with the sample liquid,
A detection cell part is formed in the same substrate in communication with the second chamber, and the inside (reacted sample o'31
A solution is introduced into the detection region and a predetermined analysis is performed (7).
以下図面に示した実施例に基づ′さオ\発明を説明する
。The invention will be explained below based on the embodiments shown in the drawings.
第2図は木R1明の主要部を示−!l縦断面図、第3図
は第2図の△−Δ所面図であり、5(31、耐檗品11
に優れたガラス・1υレラミツク等(゛形成された基体
であり、内部に部屋6,7.及び8が設(Jられ℃いる
。第1の部屋6と第2の部専7どの間はa9い透析膜9
−C・仕切られ−Cおり、第1の部1〃には検査リベさ
白液ヤI/J(,,qの試料液が導入I」10 h+
+ら導入され、検査後の液(よtJl出口11から排出
される。Figure 2 shows the main part of the tree R1 light! l Longitudinal cross-sectional view, Figure 3 is a △-Δ section view of Figure 2.
It is a base made of excellent glass, 1υreramikku, etc., and there are rooms 6, 7, and 8 inside.The space between the first room 6 and the second room 7 is Dialysis membrane 9
-C・Separated by -C, and the first part 1 contains the white liquid for inspection.
The liquid after inspection is discharged from the outlet 11.
前記第2の部屋の中には固定化酵素12が充填されてd
5す、透析II!、!9を通過した試オ′!1分子(糖
)と酵素反応りる。該第2の部屋内には透析した試オ′
31液の抽出及び若しくは該試料液と化学反応を行4z
う緩t!Iii液が導入口13を介しC導入される。前
記固定化酵素は2種又はそれ以上が混ぜl〔状態で充填
されており、両酵素を媒介にして緩衝液の発色反Li1
iが遂行されるように椙成している。前記第2の部屋内
で一発色した、又は発色過程の試料液は通路14を介し
て検出レルiji S内に導入され、静止 ′状態に保
持される。該検出セル部の上方にはAブーjイノJルフ
ァイバ15の一端が設岡され、その池幅;に配置された
レンズ16及びフィルタ17を介しく光源18より所定
11i波長の光束が導入され、基体5を通して検出セル
部に前用される。該検出レル部において発色した試料溶
液にJ、り吸収された光束は更に基体を通過して)71
−1〜ダイA−ド等の光検出器19により検出される。The second chamber is filled with immobilized enzyme 12.
5. Dialysis II! ,! Trial pass 9! An enzymatic reaction occurs with one molecule (sugar). The second room contains dialyzed samples.
Extract the 31 liquid and/or perform a chemical reaction with the sample liquid 4z
It's easy! Liquid C is introduced through the inlet 13. Two or more types of the immobilized enzymes are packed in a mixed state, and both enzymes are used as a mediator to color the buffer solution.
I am working hard to ensure that i is carried out. The sample liquid that has developed one color or is in the process of developing color in the second chamber is introduced into the detection rail iji S through the passage 14 and kept in a stationary state. Above the detection cell section, one end of an A-boole fiber 15 is installed, and a light beam of a predetermined 11i wavelength is introduced from a light source 18 through a lens 16 and a filter 17 arranged at the width of the fiber. It is applied to the detection cell part through the base body 5. The light flux absorbed by the colored sample solution in the detection region further passes through the substrate)71
Detected by a photodetector 19 such as -1 to A-1.
検出の終了した試第11溶)イシは初出I」20より排
出液槽(図示lず)に廃0!される。第4図は前記第2
図及び第3図に示した分析デバイス八を使用した分析装
置全体の概略図Cあり、試オ′3i液導入し110は試
1′81注入器21に接続し、該注入器より直接血液が
第2図の第1の部屋6内に注入される。緩衝液導入[」
13は切換え弁22を介しCポンプ23に接続し、緩衝
液4iV 24内の緩衝液が第2の部屋7内に注入でき
る。25は洗浄液槽Cあり、例えば血)1にと同じ塩濃
度の0.8%の食塩水が注入し−Cあり、該洗(予液は
ポンプ26により吸い上げられ、切換え弁22を介し゛
く、成るいは弁27を介しく1)q記試)31液注入器
21に導入Cきる。又、ノ″バーイスΔのJJI ++
4020からの廃液は廃液槽28に貯留される。光検出
器゛19の出力は増幅器29を介し−C信シ号処理回路
30に送られ、適宜処理された後、記録又は表示装置3
1に送られ、分析〈検査)結果が表示される。Detection was completed in the test No. 11 solution) The first appearance I"20 was discarded into the drain tank (not shown). be done. Figure 4 shows the second
There is a schematic diagram C of the entire analyzer using the analytical device 8 shown in Fig. 1 and Fig. 3. Sample O'3i liquid is introduced and 110 is connected to the sample 1'81 syringe 21, and blood is directly supplied from the syringe. It is injected into the first chamber 6 of FIG. Introducing buffer solution
13 is connected to a C pump 23 via a switching valve 22, so that the buffer solution in the buffer solution 4iV 24 can be injected into the second chamber 7. 25 is a washing liquid tank C, in which 0.8% saline solution having the same salt concentration as in 1 is injected (for example, blood); , or through the valve 27 1) q test) 31 can be introduced into the liquid injector 21 . Also, the JJI ++ of No″Bice Δ
The waste liquid from 4020 is stored in the waste liquid tank 28. The output of the photodetector 19 is sent to the -C signal processing circuit 30 via the amplifier 29, and after being appropriately processed, it is sent to the recording or display device 3.
1, and the analysis (test) results are displayed.
以上のにうなデバイスを使用した装置l゛iに、13い
て、血液中のグル」−スの検査を行なう場合につい(説
明り−る。先ず、第2図におりる5’a 4ij l!
Aとしては数乃至数十μの厚さのセロハンやビニール系
、又はポリカーボネー1〜系の多孔質高分子物質が選択
される。この様な透析膜を用いIX区画された部屋7内
にグルコース Aキシディス及びベルオキシディスを適
宜混合した固定化酵素を充1建し、該部屋内にポンプ2
3によって4アミ21アンチビリンを3右した緩衝液を
導入しておき、第1の部屋内に試料(1を注入器21か
ら採血した血液を注入づる。I will explain the case in which a test for glucose in blood is carried out using an apparatus using the above-mentioned device.
As A, a porous polymeric material such as cellophane, vinyl, or polycarbonate having a thickness of several to several tens of microns is selected. Using such a dialysis membrane, an immobilized enzyme containing an appropriate mixture of glucose Axidis and Beroxidis was placed in the IX-divided room 7, and a pump 2 was installed in the room.
Introduce a buffer solution containing 4-21 antivirin by 3 and inject the sample (blood collected from syringe 21 into the first chamber) into the first chamber.
この様な状況にJ3い−C1面中の糖、例えばグルコー
スは白球に比較して筋かに分子量が小さいので、該グル
コースは前記透析膜9の多数の小さな孔を通過しC第2
の部屋γ内に浸入りる。この浸入したグルー1−スは充
填され−Cいる固定化酵素のグルコース 副キシディス
と酵素反応を起しグルコン酸ど過酸化水素に分解される
。この過酸化水素は恒Vじく部屋7内に固定されたベル
Δキシディスを触媒にし−C該部屋内の4)7ミノアン
ヂピリンと化2ノつ反応を起しC光色りる。この発色の
程1αは過n!:化水系のLiに比例Jるので、透析膜
519から浸透しCぎたグルコースの屯に応じた発色現
象か得られ、検体どしての血液に応じた化色測γが可能
となる。In such a situation, sugars in the J3-C1 plane, such as glucose, have a significantly smaller molecular weight than white spheres, so the glucose passes through the many small pores of the dialysis membrane 9 and becomes the C2
enters the room γ. This infiltrated glucose undergoes an enzymatic reaction with the immobilized enzyme charged with glucose, and is decomposed into gluconic acid and hydrogen peroxide. This hydrogen peroxide causes a chemical reaction with the 4)7-minoandipyrine in the chamber 7 using the Δxydis fixed in the chamber 7 as a catalyst, producing a C light color. The level of color development is 1α! : Since Li is proportional to Li in the dialysis membrane, a coloring phenomenon corresponding to the amount of glucose permeated from the dialysis membrane 519 can be obtained, and color measurement γ can be performed according to the amount of blood as a sample.
前記第1の部屋6から第2の部屋7への分子の浸入、成
るいは透析は[1的物の淵麿着にJ、るので、初11に
おいては第2の部屋はグルコースの1農度が0であるの
で極めて速やかにグルコースの透析が行なわれる。そし
て、透析が進行づると浸入した目的物(グルコース)は
固定化酵素と反応を起し、濃度が低下していくため、更
にその分子は透析が進行する。しかし、透析した分子の
内反応にあずからない分子は第1の部屋の濃度と211
2の部14号の濶瓜とが等しくなった状態で]♂llr
はス(・ツブする。The infiltration, or dialysis, of molecules from the first chamber 6 to the second chamber 7 involves the arrival of one substance at the bottom, so that at the beginning 11 the second chamber contains only one molecule of glucose. Since the temperature is 0, glucose dialysis is performed very quickly. Then, as dialysis progresses, the target substance (glucose) that has entered reacts with the immobilized enzyme and its concentration decreases, so that the molecule progresses further in dialysis. However, the molecules that do not participate in the internal reaction of the dialyzed molecules have a concentration of 211
2, part 14, in a state where they are equal] ♂llr
Hassu(・tsubutsu).
このようにして目的と覆る分子が極めて効宋的にり〕2
の部屋に抽出され、lli’;素反応を生起して発色現
象が進行りる。予め設定した11.1間経過後、第2の
部屋の溶液をポンプ23を作動さけて検出レル部8内に
送り込み、単色光束を照!Jll してイの液体にJ、
る吸光度の測定を行なう。測定の結果【よ記録t1又は
表示装置31に記録される。1−J定のj、Il″A′
81の検査が終了した場合、切換え弁22を切換え、又
弁27を聞さ、ポンプ2Gを作動さuC洗浄液を第1の
部屋6及び第2の部屋7内にン勺入りる。この洗汀l液
どしCは0.8%の食塩水が使用され(いるので、血球
の破壊なしに各部屋内を綺Hfiに)′+1化Cぎる。In this way, the molecules that cover the purpose become extremely effective〕2
It is extracted into the chamber, and an elemental reaction occurs, and the coloring phenomenon progresses. After a preset period of 11.1 minutes has elapsed, the solution in the second chamber is pumped into the detection barrel 8 without operating the pump 23, and illuminated with a monochromatic light beam! Jll to the liquid J,
Measure the absorbance. The measurement results are recorded in the record t1 or on the display device 31. 1-J constant j, Il″A′
When the test 81 is completed, the changeover valve 22 is switched, the valve 27 is turned on, and the pump 2G is operated to pump the uC cleaning liquid into the first chamber 6 and the second chamber 7. This washing liquid C uses 0.8% saline solution (because it contains saline, it cleans the inside of each room without destroying blood cells).
実際の装置ではこの食塩水の使用の後、真水J、る洗浄
を行なうように(j4成りると良い。In an actual device, after using this saline solution, it is recommended to wash with fresh water (J4).
以1説明したような分析デバイスを使用りるど、+m
JAt分離−分注−分析(反応)−測定のプロセスが単
一のチップ内で全C実行てきるのC゛、第1図にJ3い
て点線で示した採血(1)から直ちに分析(/I)へ移
行でき、緊急検体の検査に最適く゛ある。When using an analytical device such as the one described above, +m
The process of JAt separation, dispensing, analysis (reaction) and measurement can be carried out in a single chip. ), making it ideal for testing emergency specimens.
しか−6、装置tは非1:1゛に生型になり1つ試わ]
液や緩衝液等の移動のための榔411が不要で、配管も
必要4τいのC′装置が111純化−C・き、りL1ス
コンタミの問題も生しない。But -6, the device t becomes a non-1:1 raw type and tries one]
The C' device, which does not require a sill 411 for moving liquids, buffers, etc., and requires 4τ piping, does not cause the problem of 111 purification-C/reli L1 scontamination.
尚、上記透析膜9、固定化酵素及び緩衝液は分411又
は検査りる蛋白質の種類に応じて最適なものが選択され
る。The dialysis membrane 9, immobilized enzyme, and buffer are selected optimally depending on the type of protein to be tested.
第5図は不発明の他の実施例であり、第1及びガ′82
の部屋の形状の例を示づものである。図J、り明らか4
fJ、うに、部屋6及び7(6は図示ゼ−ず)は蛇行し
た形状に作られ、効率的に試料液が5A20部屋に浸透
し且つ該浸透した試片31液が固定化酵素と有効に反応
するように工夫しである。勿論、第5図の形状も一例で
あり、この形状が最良とは限らない。FIG. 5 shows another embodiment of the invention;
This figure shows an example of the shape of a room. Figure J, clear 4
fJ, sea urchin, chambers 6 and 7 (6 is not shown in the figure) are made in a meandering shape so that the sample solution can efficiently penetrate into the 5A20 chamber and the permeated specimen 31 solution can effectively interact with the immobilized enzyme. It is designed to react. Of course, the shape shown in FIG. 5 is also an example, and this shape is not necessarily the best.
第6図は本発明の更に他の実施例を示づ□もので、検出
手段どし−C−比色測定に代えてへ12索);Z)其の
検出手段を使用りる場合である。図中第2図と同符号は
同1!な構成を示し“Cおり、検出レル部8内には酸素
電極32が注入されている。1)り述したにうに酵素反
応の過程においC1過n!目ヒ水素が発生し、該過酸化
水素と仙の緩衝液と反応りる過程で酸素を敢出し、これ
が溶存酸與として溶液中存在りる。FIG. 6 shows still another embodiment of the present invention, in which the detection means is used instead of colorimetric measurement; . In the figure, the same symbols as in Figure 2 are the same 1! 1) In the process of the enzymatic reaction described above, arsenic is generated, and the peroxide During the reaction between hydrogen and the buffer solution, oxygen is released, which exists in the solution as dissolved acid.
この溶存酸素を酸素電極32により測定りると第2の部
屋内で酵素反応を起しkC目的どリ−る糖の(11が実
測できるわ【プである。When this dissolved oxygen is measured by the oxygen electrode 32, an enzymatic reaction occurs in the second chamber, and kC (kC) of sugar (11) can be actually measured.
第7図は本発明づ)析デ′バイスのI:J3 III
IVI+を承りもの(・、複数個の分析デバイス△1.
△2 、 A3 。Figure 7 shows I:J3 III of the analytical device according to the present invention.
IVI+ (・, multiple analytical devices △1.
△2, A3.
・・・・・・を両列に接続し、異なった糖(5+J /
、った分子量の分子)を夫々のデバイスにより順次測定
りるJ、うに414成したものである。即ち、第1のデ
バイスの試料液?」]入D 10 aから入った試料(
よ排出口′11aから出C第2のデバイスA2の試):
jl tl、入Li10bに入り、該第2のデバイス内
に入った試料液は排出口11bから第3のデバイス△3
の注入口10Gに入るように構成しである。又、夫々の
デバイスには測定手段として光源18a、181)。....... are connected to both columns, and different sugars (5+J/
, the molecular weight of each molecule) is measured sequentially using each device. That is, the sample liquid of the first device? ”] Input D 10 Sample entered from a (
Output from the outlet '11a (test of second device A2):
jl tl, the sample liquid enters the input Li 10b and enters the second device from the discharge port 11b to the third device △3
It is configured so that it enters the injection port 10G of. Each device also has a light source 18a, 181) as a measuring means.
18c ”’ ”’及び光検出器19a、19b、19
c・・・・・・が設()られている。勿論、各デバイス
内の固定化07素の押力1や緩衝液の種り、n、更には
透析膜の種類及び厚さ等(よ測定9゛るヤ、iiの種類
に応じて最適なしのが使用されている。18c ``'''''' and photodetectors 19a, 19b, 19
c.... is set (). Of course, depending on the pressing force of the immobilization element in each device, the type of buffer solution, the type and thickness of the dialysis membrane, etc. is used.
第8図は更に他の実施例であり、第2図の実施例では複
数の固定化酵素を混合しく第2の部屋7内に充填したが
、ここでは2種の固定化酵素を分丙(して異なった部屋
内に充填りるIff成である。111)ら、第2の部屋
と検出セル部8との間に第3の部屋33を形成し、該部
屋内に第2の部屋内の固定化酵素どは周なる固定化酵素
34を充填しくある。FIG. 8 shows still another example. In the example of FIG. 2, a plurality of immobilized enzymes were mixed and filled into the second chamber 7, but here two types of immobilized enzymes were mixed and filled ( 111), a third chamber 33 is formed between the second chamber and the detection cell section 8, and a third chamber 33 is formed between the second chamber and the detection cell section 8, The immobilized enzyme is filled with surrounding immobilized enzyme 34.
そして、第2の部屋7ど第3の部1ギ33どの間に第2
の緩衝液の注入口35が設りられ、第2の部屋7内に注
入される緩衝液とは箕なる緩衝液がシ9人される。勿論
、必要であれば更に異なった固定化酵素の充填された部
屋を設り−(心良い。Then, between the second room 7 and the third section 1gi 33, the second room
A buffer solution inlet 35 is provided, and a buffer solution that is different from the buffer solution injected into the second chamber 7 is supplied. Of course, if necessary, a room filled with different types of immobilized enzymes can be provided.
この様な構成とJれば、13から注入す゛る第1の緩衝
液は第1 ’7) fits屋θ内の試に’jlから所
望とりる糖のみを抽出りるに最適なものが選択(・き、
このJ:うにし−C効率的に抽出された糖と固定化酵素
と反応した溶液に発色反応に最適な第2の緩衝液を第2
の注入口35から注入づることか可能となり、効率的な
測定が行なえる。With such a configuration, the first buffer injected from step 13 is the first buffer solution (7).The one that is most suitable for extracting only the desired sugar from the fit store is selected (7). ·tree,
A second buffer solution optimal for color reaction is added to the solution in which the sugars efficiently extracted from sea urchin-C react with the immobilized enzyme.
It is now possible to inject from the injection port 35, allowing efficient measurement.
第9図は更に他の実施例であり、酵素反応と化学反応と
を引合わせたもの(・ある。第2の部屋7と検出レル部
8との間に反応試檗注入+13(3を設(プ、該>J−
人口より反応試話を注入し′(第2の部屋で生成された
酵素反応生成物と化学反応を起さけ、その結果生じIこ
発色の程度を吸光1す測定りるように構成しCある。FIG. 9 shows still another embodiment, in which an enzymatic reaction and a chemical reaction are combined. (P, >J-
A reaction test sample was injected from the human body (a chemical reaction was caused with the enzymatic reaction product produced in the second chamber), and the resulting color was measured by absorbance. .
以−L説明したj、うなii+i成どなけは、採血した
血液を直接分4バデバイスC分析でき、f+L米の様に
静置・凝固や遠心分1411器を使用しくの血清の分(
bll・分注等が不要となり、極めC迅速な測定が可能
となり、閉急検体の検査に有効(・(イる。In case of j, eel ii+i as explained above, the collected blood can be analyzed directly in the aliquot device C, and the blood serum can be analyzed by standing, coagulating or centrifuging as in f+L rice.
It eliminates the need for BLL, pipetting, etc., enables extremely rapid measurement, and is effective for testing urgent samples.
第1図は従来の臨床化学分析の流れを承り図、第2図は
本発明の一実施例を示す分析デバイスの縦断面図、第3
図は第2図のA−A断面図、第4図は第2図のデバイス
を使用した分析装置の概略を示1図、第j図乃至第9図
は夫々本発明の他の実施例を承り図でd5る。
5:M体
6:第1の部屋
7:第2の部屋
8:検出セル部
9:透析膜
10:試オ′l注入1]
11:試料排出口
12:固定化酵素
13 : PAii液注入口
15ニゲラスフアイバ
16:光学レンズ
゛17:フイルタ
18:光源
19:光検出器
第1図
71ぐ
第4図
第6図
第7図Fig. 1 is a diagram showing the flow of conventional clinical chemistry analysis, Fig. 2 is a vertical sectional view of an analytical device showing an embodiment of the present invention, and Fig. 3
The figure is a sectional view taken along the line A-A in FIG. 2, FIG. 4 is a schematic diagram of an analyzer using the device shown in FIG. 2, and FIGS. d5 on the acceptance drawing. 5: M body 6: First chamber 7: Second chamber 8: Detection cell section 9: Dialysis membrane 10: Sample fluid injection 1] 11: Sample outlet 12: Immobilized enzyme 13: PAii liquid inlet 15 Nigel fiber 16: Optical lens 17: Filter 18: Light source 19: Photodetector Fig. 1 71 Fig. 4 Fig. 6 Fig. 7
Claims (1)
i tlべき試料液を尋人し、第2の部用には固定化酵
素を充填すると共に透析膜を通過した試料液を抽出及び
若しくは該試料液と反応Jる溶液を注入し、前記第2の
部屋に連通して同−基体内に検出レル部を形成し、前記
第2の部屋内で反応した試料溶液を該検出セル部に導入
して所定の分析を行なうように414成し1〔臨床分析
用分析デバイス。 く2)前記第2の部屋に充填される固定化酵素は複数種
類である特許請求の範囲第1項記載の臨床分析用分析デ
バイス。 (3) +ijr記第2の部屋と検出セル部との間に少
なくとも1個の部屋を形成し、該部屋内に第2の部屋内
に充填した固定化酵素とは異なる酵素を充1眞しである
特許請求の範囲第1項記載の臨床分析用分析デバイス。 (4)前記第2の部屋と検出セル部との間に酵素反応生
成物と化学反応を起り一試檗の注入口を設りた特許請求
の範UIJJ第1項又1J第2 iH記載の臨床分析用
分析デバイス。 (5)前記第1の部屋から排出された試)3+液1.L
他の分析デバイスの第1の部屋内に導入される特H’1
請求の範囲第1項IIJ至第4項のいずれかに記載の臨
床分析用分析デバイス。[Scope of Claims] (1) Single) "Separated by a thin porous dialysis membrane inside the body. Forming two rooms separated, the first room has 4J'
The second part is filled with immobilized enzyme, and the sample liquid that has passed through the dialysis membrane is extracted and/or a solution that reacts with the sample liquid is injected. A detection cell part is formed in the base body in communication with the second chamber, and a sample solution reacted in the second chamber is introduced into the detection cell part to perform a predetermined analysis. Analytical device for clinical analysis. 2) The analytical device for clinical analysis according to claim 1, wherein the second chamber is filled with a plurality of types of immobilized enzymes. (3) Form at least one chamber between the second chamber and the detection cell section, and fill the chamber with an enzyme different from the immobilized enzyme filled in the second chamber. An analytical device for clinical analysis according to claim 1. (4) An inlet for causing a chemical reaction with an enzyme reaction product between the second chamber and the detection cell section is provided, as set forth in Claim UIJJ Paragraph 1 or 1J Paragraph 2 iH. Analytical device for clinical analysis. (5) Sample) 3+liquid 1. discharged from the first chamber. L
Special H'1 introduced into the first chamber of another analytical device
An analytical device for clinical analysis according to any one of claims 1 to 4.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58204291A JPS6095357A (en) | 1983-10-31 | 1983-10-31 | Analyzing device for crinical analysis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58204291A JPS6095357A (en) | 1983-10-31 | 1983-10-31 | Analyzing device for crinical analysis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6095357A true JPS6095357A (en) | 1985-05-28 |
| JPH0217077B2 JPH0217077B2 (en) | 1990-04-19 |
Family
ID=16488044
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58204291A Granted JPS6095357A (en) | 1983-10-31 | 1983-10-31 | Analyzing device for crinical analysis |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6095357A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007097510A (en) * | 2005-10-05 | 2007-04-19 | Univ Waseda | Micro reactor |
| KR100729931B1 (en) | 2006-02-28 | 2007-06-18 | 성균관대학교산학협력단 | Microfluidic Devices for Sample Concentration Amplification |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0428076U (en) * | 1990-03-09 | 1992-03-05 |
-
1983
- 1983-10-31 JP JP58204291A patent/JPS6095357A/en active Granted
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007097510A (en) * | 2005-10-05 | 2007-04-19 | Univ Waseda | Micro reactor |
| KR100729931B1 (en) | 2006-02-28 | 2007-06-18 | 성균관대학교산학협력단 | Microfluidic Devices for Sample Concentration Amplification |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0217077B2 (en) | 1990-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3733179A (en) | Method and apparatus for the quantitative determination of blood chemicals in blood derivatives | |
| KR101355126B1 (en) | Biochemical assay cartridge | |
| KR101352900B1 (en) | Biochemical assay cartridge with improved operability | |
| JPH10501425A (en) | Measuring device for analytes in liquid samples | |
| EP0136362A1 (en) | Biosensor | |
| CN103276052B (en) | A kind of Urea nitrogen detection reagent | |
| US4311789A (en) | Method for sampling and measuring the content of a low-molecular weight compound in a complex fluid medium | |
| CN103278648B (en) | Albumin detection reagent | |
| US7002670B2 (en) | Optical sensor and method for measuring concentration of a chemical constituent using its intrinsic optical absorbance | |
| ATE133453T1 (en) | METHOD FOR DETERMINING GLUCOSE IN WHOLE BLOOD AND VESSEL AND PHOTOMETER FOR PERFORMING THIS METHOD | |
| AU708196B2 (en) | Process and device for determining the activity of enzymes in liquids, or the concentration and/or activity of inhibitors in liquids | |
| JPH0559380B2 (en) | ||
| CN107966578B (en) | Medical rapid biochemical detection system and detection method | |
| CN103278469B (en) | A kind of total protein detection reagent | |
| Zhou et al. | Point-of-care testing of four chronic disease biomarkers in blood based on a low cost and low system complexity microfluidic chip with integrated oxygen-sensitive membrane | |
| CN111495451A (en) | Biochemical index detection integrated chip and detection method and application thereof | |
| Lu et al. | Rapid microfluidic fluorescence detection platform for determination of whole blood sodium | |
| EP1092978A1 (en) | Method and device for determining the concentration of heparin in a sample of fluid | |
| JPS6095357A (en) | Analyzing device for crinical analysis | |
| JPS589050A (en) | Method and device for measuring endotoxin content | |
| Baxter et al. | Simultaneous Haptoglobin and Haemoglobin Typing off Blood and Bloodstains using Gradient Polyacrylamide Gel Electrophoresis | |
| CN113267460A (en) | Urine biochemical detection system for disc type micro-fluidic chip | |
| CN118599627A (en) | Centrifugal microfluidic platform and nucleic acid extraction and amplification method thereof | |
| JPS6325301B2 (en) | ||
| CN212410432U (en) | Microfluidic system for joint detection of blood amylase and alkaline phosphatase |